首页 >
法规速递
-
Document: Medicine shortage communication (MSC): Natpar (parathyroid hormone) (25, 50, 75 and 100 micrograms/dose powder and solvent for solution for injection)-2026/2/13
2026-02-14查看详情 > -
Page: Clinical investigation of medicinal products in the treatment of Myasthenia Gravis-2026/2/13
2026-02-14查看详情 > -
Document: Concept paper on the need of a guideline on clinical investigation of medicinal products in the treatment of Myasthenia Gravis-2026/2/13
2026-02-14查看详情 > -
Page: Paediatric investigation plans: questions and answers-2026/2/12
2026-02-13查看详情 > -
Document: Review of the stepwise paediatric investigation plan (sPIP) pilot: Outcomes and future perspectives-2026/2/12
2026-02-13查看详情 > -
Page: Paediatric investigation plans-2026/212
2026-02-13查看详情 > -
Document: Guidance for applicants for the preparation of the precise scope section of the variation application form-2026/2/12
2026-02-13查看详情 > -
Page: CVMP recommendations on limited market classification and eligibility for authorisation under Article 23-2026/2/12
2026-02-13查看详情 > -
Document: Minutes of the PRAC meeting 24 - 27 November 2025-2026/2/12
2026-02-13查看详情 > -
Document: Antimicrobial Sales and Use (ASU) Platform: Release notes-2026/2/12
2026-02-13查看详情 >
